Renato D. Lópes

63.9k total citations · 9 hit papers
623 papers, 21.5k citations indexed

About

Renato D. Lópes is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Renato D. Lópes has authored 623 papers receiving a total of 21.5k indexed citations (citations by other indexed papers that have themselves been cited), including 463 papers in Cardiology and Cardiovascular Medicine, 126 papers in Surgery and 94 papers in Internal Medicine. Recurrent topics in Renato D. Lópes's work include Atrial Fibrillation Management and Outcomes (261 papers), Antiplatelet Therapy and Cardiovascular Diseases (129 papers) and Cardiac Arrhythmias and Treatments (119 papers). Renato D. Lópes is often cited by papers focused on Atrial Fibrillation Management and Outcomes (261 papers), Antiplatelet Therapy and Cardiovascular Diseases (129 papers) and Cardiac Arrhythmias and Treatments (119 papers). Renato D. Lópes collaborates with scholars based in United States, Canada and Brazil. Renato D. Lópes's co-authors include John H. Alexander, Christopher B. Granger, Lars Wallentin, Elaine M. Hylek, Deepak L. Bhatt, Ziad Hijazi, Robert A. Harrington, Laine Thomas, Michael G. Hanna and Daniel Wojdyla and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Renato D. Lópes

576 papers receiving 21.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

2020 1.2k citations Deepak L. Bhatt, Michael Szarek et al. New England Journal of Medicine profile →
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

2021 921 citations Naveed Sattar, Kelley R. Branch et al. profile →
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

2020 789 citations Deepak L. Bhatt, Michael Szarek et al. New England Journal of Medicine profile →
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes

2021 503 citations Hertzel C. Gerstein, Naveed Sattar et al. New England Journal of Medicine profile →
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial

2012 422 citations Ziad Hijazi, John H. Alexander et al. profile →
Diagnosis and Treatment of Acute Coronary Syndromes

2022 404 citations Deepak L. Bhatt, Renato D. Lópes et al. profile →
The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

2016 330 citations Ziad Hijazi, Jonas Oldgren et al. profile →
The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

2016 284 citations Ziad Hijazi, Johan Lindbäck et al. profile →
Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials

2023 100 citations Christopher B. Granger, Stuart J. Connolly et al. Circulation profile →

Peers

Countries citing papers authored by Renato D. Lópes

Since Specialization

Citations

This map shows the geographic impact of Renato D. Lópes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renato D. Lópes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renato D. Lópes more than expected).

Fields of papers citing papers by Renato D. Lópes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renato D. Lópes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renato D. Lópes. The network helps show where Renato D. Lópes may publish in the future.

Co-authorship network of co-authors of Renato D. Lópes

This figure shows the co-authorship network connecting the top 25 collaborators of Renato D. Lópes. A scholar is included among the top collaborators of Renato D. Lópes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renato D. Lópes. Renato D. Lópes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Record-Breaking Endurance of 366 Marathons in 366 Days: A Case Study 2025 ·Arquivos Brasileiros de Cardiologia ·Francis Ribeiro de Souza, Renato D. Lópes, Guilherme Wesley Peixoto da Fonseca, Rodrigo Bellio de Mattos Barretto, (unknown), (unknown), Roberto Kalil Filho, (unknown)	0
2	Apixaban Dose in Patients With Atrial Fibrillation and Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention 2025 ·JACC Advances ·Marat Fudim, Renato D. Lópes, Daniel Wojdyla, Roxana Mehran, Muhammad Shahzeb Khan, Christopher B. Granger, Shaun G. Goodman, (unknown), (unknown), John H. Alexander	1
3	Effect of Screening for Undiagnosed Atrial Fibrillation on Stroke Prevention 2024 ·Journal of the American College of Cardiology ·Renato D. Lópes, Steven J. Atlas, Alan S. Go, (unknown), David D. McManus, Rowena J Dolor, Ranee Chatterjee, (unknown), David Rushlow, (unknown), Ronald Aronson, (unknown), Dianne Gallup, (unknown), Emily C. O’Brien, Daniel E. Singer	17
4	Antithrombotic Strategies in Atrial Fibrillation After ACS and/or PCI 2024 ·Journal of the American College of Cardiology ·(unknown), Daniel Wojdyla, Alexander C. Fanaroff, Andrzej Budaj, Christopher B. Granger, Roxana Mehran, Ronald Aronson, Stephan Windecker, Shaun G. Goodman, John H. Alexander, Renato D. Lópes	1
5	Relationship between ventricular repolarization parameters and the inducibility of ventricular arrhythmias during electrophysiological study in patients with coronary artery disease 2022 ·Revista da Associação Médica Brasileira ·(unknown), Luciana Armaganijan, Renato D. Lópes, Márcia Olandoski, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Dalmo Antônio Ribeiro Moreira	1
6	Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial 2021 ·Circulation ·Carolyn S.P. Lam, Chinthanie Ramasundarahettige, Kelley R. Branch, Naveed Sattar, Julio Rosenstock, Richard E. Pratley, Stefano Del Prato, Renato D. Lópes, Elisabeth Niemoeller, Nardev S. Khurmi, Seung Jae Baek, Hertzel C. Gerstein	82
7	Chest Pain Network with Support of Telemedicine: Impact on Reperfusion Therapy and Clinical Outcomes After 8 Years of Experience 2021 ·SHILAP Revista de lepidopterología ·Pedro Gabriel Melo de Barros e Silva, (unknown), Renato D. Lópes, (unknown), (unknown), (unknown), (unknown), (unknown), Valter Furlan	0
8	Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation 2021 ·Cardiovascular Research ·Tymon Pol, Ziad Hijazi, Johan Lindbäck, Jonas Oldgren, John H. Alexander, Stuart J. Connolly, John W. Eikelboom, Michael D. Ezekowitz, Christopher B. Granger, Renato D. Lópes, Salim Yusuf, Agneta Siegbahn, Lars Wallentin	20
9	Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas 2021 ·Open Heart ·Tymon Pol, Ziad Hijazi, Johan Lindbäck, John H. Alexander, M. Cecilia Bahit, Raffaele De Caterina, (unknown), Michael D. Ezekowitz, Bernard J. Gersh, Christopher B. Granger, Elaine M. Hylek, Renato D. Lópes, Agneta Siegbahn, Lars Wallentin	7
10	ASCEND-TD: A Randomized, Double-Blind, Active-Controlled Study of Daprodustat Administered Three Times Weekly in Hemodialysis Patients 2021 ·Journal of the American Society of Nephrology ·Daniel W. Coyne, Ajay Singh, Renato D. Lópes, Christine K. Bailey, Tara DiMino, (unknown), Jeffrey J. Connaire, Anjay Rastogi, (unknown), Marcelo Orías, Sapna Shah, Vickas Patel, Alexander R. Cobitz, Christoph Wanner	2
11	Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease breakdown → 2020 ·New England Journal of Medicine ·Deepak L. Bhatt, Michael Szarek, Bertram Pitt, Christopher P. Cannon, Lawrence A. Leiter, Darren K. McGuire, Julia B. Lewis, Matthew C. Riddle, Silvio E. Inzucchi, Mikhail Kosiborod, David Z.I. Cherney, Jamie P. Dwyer, Benjamin M. Scirica, Clifford J. Bailey, Rafael Díaz, Kausik K. Ray, Jacob A. Udell, Renato D. Lópes, Pablo Lapuerta, Philippe Gabríel Steg	789
12	Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure breakdown → 2020 ·New England Journal of Medicine ·Deepak L. Bhatt, Michael Szarek, Philippe Gabríel Steg, Christopher P. Cannon, Lawrence A. Leiter, Darren K. McGuire, Julia B. Lewis, Matthew C. Riddle, Adriaan A. Voors, Marco Metra, Lars H. Lund, Michel Komajda, Jeffrey M. Testani, Christopher S. Wilcox, Piotr Ponikowski, Renato D. Lópes, Subodh Verma, Pablo Lapuerta, Bertram Pitt	1204
13	Síndrome do desconforto respiratório agudo associada à COVID-19 tratada com DEXametasona (CoDEX): delineamento e justificativa de um estudo randomizado 2020 ·LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) ·Bruno Martins Tomazini, Israel Silva Maia, Flávia Regina Bueno, (unknown), (unknown), Eduardo Leite Vieira Costa, (unknown), (unknown), (unknown), Alexandre Biasi Cavalcanti, Régis Goulart Rosa, Álvaro Avezum, Viviane Cordeiro Veiga, Renato D. Lópes, Lucas Petri Damiani, Flávia Ribeiro Machado, Otávio Berwanger, Luciano César Pontes Azevedo	5
14	Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation 2020 ·Journal of the American Heart Association ·Ziad Hijazi, Lars Wallentin, Johan Lindbäck, John H. Alexander, Stuart J. Connolly, John W. Eikelboom, Michael D. Ezekowitz, Christopher B. Granger, Renato D. Lópes, Tymon Pol, Salim Yusuf, Jonas Oldgren, Agneta Siegbahn	41
15	Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding 2019 ·Circulation ·(unknown), Renato D. Lópes, James Aisenberg, Paul A. Reilly, Joanne van Ryn, Stephan Glund, Amelie Elsaesser, Frederikus A. Klok, Charles V. Pollack, Menno V. Huisman	29
16	Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial 2018 ·American Heart Journal ·Claes Held, Harvey D. White, Ralph Stewart, Richard Davies, (unknown), Karen Chiswell, A Silverstein, Renato D. Lópes, (unknown), Andrzej Budaj, Kenneth W. Mahaffey, Lars Wallentin	11
17	Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease 2015 ·Circulation ·Álvaro Avezum, Renato D. Lópes, Phillip J. Schulte, Fernando Laņas, Bernard J. Gersh, Michael Hanna, Prem Pais, Çetin Erol, Rafael Díaz, M. Cecilia Bahit, Jozef Bartunek, Raffaele De Caterina, Shinya Goto, Witold Rużyłło, Jun Zhu, Christopher B. Granger, John H. Alexander	166
18	Abstract 13635: Atorvastatin for the Prevention of Major Vascular Events in Patients Undergoing Non-Cardiac Surgery: The LOAD-Pilot Randomized Clinical Trial 2015 ·Circulation ·Otávio Berwanger, Rafael Marques Soares, Dimas Ikeoka, Denise Paisani, (unknown), Sabrina Bernardez‐Pereira, (unknown), P.J. Devereaux, Renato D. Lópes	1
19	Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention in the United States and Canada: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) trial 2012 ·American Heart Journal ·Rajendra H. Mehta, Padma Kaul, Renato D. Lópes, Manesh R. Patel, Yinggan Zheng, Karen S. Pieper, Robert C. Welsh, Paul W. Armstrong, Christopher B. Granger	6
20	Saphenous Vein Grafts With Multiple Versus Single Distal Targets in Patients Undergoing Coronary Artery Bypass Surgery 2011 ·Circulation ·Rajendra H. Mehta, T. Bruce Ferguson, Renato D. Lópes, Gail E. Hafley, Michael J. Mack, Nicholas T. Kouchoukos, C. Michael Gibson, Robert A. Harrington, Robert M. Califf, Eric D. Peterson, John H. Alexander	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact